Jianying Yao

605 total citations
15 papers, 440 citations indexed

About

Jianying Yao is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Jianying Yao has authored 15 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Surgery. Recurrent topics in Jianying Yao's work include Prostate Cancer Treatment and Research (5 papers), Bone health and treatments (3 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Jianying Yao is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Bone health and treatments (3 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Jianying Yao collaborates with scholars based in United States, China and France. Jianying Yao's co-authors include Ronald E. Aubert, Robert S. Epstein, J. Russell Teagarden, Ashish K. Jha, Fang Xia, Zeruesenay Desta, Todd C. Skaar, David A. Flockhart, Felix W. Frueh and Jeffrey A. Breall and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Emerging infectious diseases.

In The Last Decade

Jianying Yao

15 papers receiving 415 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jianying Yao 160 134 116 73 69 15 440
Jenifer Wogen 137 0.9× 115 0.9× 291 2.5× 42 0.6× 64 0.9× 28 714
Chandrasekar Gopalakrishnan 114 0.7× 66 0.5× 95 0.8× 66 0.9× 40 0.6× 28 553
Andreea Farcaș 61 0.4× 152 1.1× 41 0.4× 80 1.1× 143 2.1× 41 549
Stephen Kogut 133 0.8× 123 0.9× 113 1.0× 101 1.4× 124 1.8× 67 729
Daniel Pettitt 104 0.7× 45 0.3× 104 0.9× 218 3.0× 55 0.8× 15 585
Daniala L. Weir 210 1.3× 69 0.5× 315 2.7× 57 0.8× 113 1.6× 31 714
Scott V. Monte 90 0.6× 40 0.3× 54 0.5× 51 0.7× 137 2.0× 30 565
Isabelle Chabot 121 0.8× 89 0.7× 18 0.2× 152 2.1× 122 1.8× 35 494
Maja Skov Paulsen 97 0.6× 57 0.4× 19 0.2× 95 1.3× 69 1.0× 18 481
Jan Stålhammar 184 1.1× 45 0.3× 251 2.2× 67 0.9× 23 0.3× 36 580

Countries citing papers authored by Jianying Yao

Since Specialization
Citations

This map shows the geographic impact of Jianying Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianying Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianying Yao more than expected).

Fields of papers citing papers by Jianying Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianying Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianying Yao. The network helps show where Jianying Yao may publish in the future.

Co-authorship network of co-authors of Jianying Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Jianying Yao. A scholar is included among the top collaborators of Jianying Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianying Yao. Jianying Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Yao, Jianying, et al.. (2024). Adverse events and costs among non-metastatic castration-resistant prostate cancer patients. Journal of Medical Economics. 27(1). 145–152. 1 indexed citations
2.
Freedland, Stephen J., Jianying Yao, Yuxian Du, et al.. (2021). Real-world clinical adverse events (AEs) among nonmetastatic castration-resistant prostate cancer (nmCRPC) patients treated with novel anti-androgen (AA) therapies: A retrospective database study.. Journal of Clinical Oncology. 39(15_suppl). e18675–e18675. 2 indexed citations
3.
Liu, Jiao, Jianying Yao, Lidi Zhang, et al.. (2020). Surfactant protein D (SP-D) gene polymorphism rs721917 is an independent predictor of acute kidney injury development in sepsis patients: a prospective cohort study. Annals of Intensive Care. 10(1). 5–5. 1 indexed citations
4.
Wen, Lonnie, Jianying Yao, & Adriana Valderrama. (2019). Evaluation of Treatment Patterns and Costs in Patients with Prostate Cancer and Bone Metastases. Journal of Managed Care & Specialty Pharmacy. 25(3-b Suppl). S1–S11. 21 indexed citations
5.
Zhong, Yue, et al.. (2017). Economic Evaluation of Treating Skeletal-Related Events among Prostate Cancer Patients. Value in Health. 21(3). 304–309. 10 indexed citations
6.
7.
8.
Yao, Jianying, et al.. (2017). Evaluation of treatment patterns and costs for patients with prostate cancer and bone metastases.. Journal of Clinical Oncology. 35(6_suppl). 215–215. 1 indexed citations
9.
Seal, Brian, Jianying Yao, Jonathan Kish, Dana Stafkey-Mailey, & Michael Eaddy. (2014). Evaluation of national treatment trends in ovarian cancer.. Journal of Clinical Oncology. 32(30_suppl). 204–204. 1 indexed citations
10.
Jha, Ashish K., Ronald E. Aubert, Jianying Yao, J. Russell Teagarden, & Robert S. Epstein. (2012). Greater Adherence To Diabetes Drugs Is Linked To Less Hospital Use And Could Save Nearly $5 Billion Annually. Health Affairs. 31(8). 1836–1846. 144 indexed citations
11.
Aubert, Ronald E., et al.. (2010). Is there a relationship between early statin compliance and a reduction in healthcare utilization?. PubMed. 16(6). 459–66. 51 indexed citations
12.
Kreutz, Rolf P., Eric J. Stanek, Ronald E. Aubert, et al.. (2010). Impact of Proton Pump Inhibitors on the Effectiveness of Clopidogrel After Coronary Stent Placement: The Clopidogrel Medco Outcomes Study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(8). 787–796. 97 indexed citations
13.
Ortiz, Justin R., Laurie Kamimoto, Ronald E. Aubert, et al.. (2008). Oseltamivir Prescribing in Pharmacy-Benefits Database, United States, 2004–20051. Emerging infectious diseases. 14(8). 1280–1283. 15 indexed citations
14.
Aubert, Ronald E., Robert S. Epstein, J. Russell Teagarden, et al.. (2008). Abstract 3998: Proton Pump Inhibitors Effect on Clopidogrel Effectiveness: The Clopidogrel Medco Outcomes Study. Circulation. 118(suppl_18). 65 indexed citations
15.
Stettin, Glen, et al.. (2006). Frequency of follow-up care for adult and pediatric patients during initiation of antidepressant therapy.. PubMed. 12(8). 453–61. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jenifer Wogen Breakdown of academic impact, for papers by Chandrasekar Gopalakrishnan Breakdown of academic impact, for papers by Andreea Farcaș Breakdown of academic impact, for papers by Stephen Kogut Breakdown of academic impact, for papers by Daniel Pettitt Breakdown of academic impact, for papers by Daniala L. Weir Breakdown of academic impact, for papers by Scott V. Monte Breakdown of academic impact, for papers by Isabelle Chabot Breakdown of academic impact, for papers by Maja Skov Paulsen Breakdown of academic impact, for papers by Jan Stålhammar
Rankless by CCL
2026